RA Capital Healthcare Fund LP
Insider CIK 1315082 · SGMO · ACHN 10% owner · KALV 10% owner · DRNA 10% owner · KALA Director, 10% owner · RARX Director, 10% owner · VSTM 10% owner · FMTX Director, 10% owner · ACRS 10% owner · GTHX · ABOS Director, 10% owner · SCPH 10% owner · THOR 10% owner · CDTX Director, 10% owner · WVE Director, 10% owner · DICE Director, 10% owner · PCVX 10% owner · RYTM 10% owner · FDMT 10% owner · ARVN · PBLS Director, 10% owner · ITRM 10% owner · SPRY Director, 10% owner · IMRA 10% owner · PRLD 10% owner · FULC 10% owner · STSA Director, 10% owner · BDTX Director · SLDB Director, 10% owner · ACET 10% owner · AKUS 10% owner · EIDX 10% owner · ORTX Director, 10% owner · IKT 10% owner · CLYM Director, 10% owner · SGP Director, 10% owner · ACRV Director, 10% owner · BOLD 10% owner · PHAT 10% owner · ETNB Director, 10% owner · HOWL Director, 10% owner · ICVX Director, 10% owner · NKTX Director, 10% owner · AVTE Director, 10% owner · ITOS Director, 10% owner · RACA Director · LENZ Director, 10% owner · VOR Director, 10% owner · ARTV Director, 10% owner · JANX Director, 10% owner · CTKB Director, 10% owner · PEPG Director, 10% owner · TYRA Director, 10% owner · ANTX 10% owner · MLYS Director, 10% owner · SEPN Director, 10% owner · FRNM Director, 10% owner · BCAX Director, 10% owner · SION Director, 10% owner · EVMN Director · COAG Director, 10% owner · DSCI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ Therapeutics, Inc. | S Sale | 2026-10-29 | 2026-11-02 | 107,170 | $3.36 | $360.1K | 57,559 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2026-10-29 | 2026-11-02 | 451,998 | $3.36 | $1.52M | 242,757 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | S Sale | 2026-10-29 | 2026-11-02 | 2,159,516 | $3.36 | $7.26M | 1,159,823 | SEC↗ |
| WVE Wave Life Sciences, Inc. | A Award deriv | 2026-10-05 | 2026-10-07 | 64,000 | — | $0 | 64,000 | SEC↗ |
| WVE Wave Life Sciences, Inc. | A Award | 2026-10-05 | 2026-10-07 | 10,700 | — | $0 | 39,515 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise deriv | 2026-10-02 | 2026-10-05 | 500 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise | 2026-10-02 | 2026-10-05 | 500 | $12.80 | $6.4K | 500 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 40,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise deriv | 2026-09-28 | 2026-09-30 | 10,000 | — | $0 | 0 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 40,000 | $1.29 | $51.6K | 70,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $7.89 | $78.9K | 30,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.00 | $30.0K | 20,000 | SEC↗ |
| CLYM Climb Bio, Inc. | M Exercise | 2026-09-28 | 2026-09-30 | 10,000 | $3.46 | $34.6K | 10,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 33,800 | $7.46 | $252.1K | 3,448,812 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2026-09-17 | 2026-09-21 | 3,415,011 | $6.32 | $21.58M | 3,482,612 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy deriv | 2026-09-15 | 2026-09-17 | 9,078,529 | $22.03 | $200.00M | 11,616,986 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy deriv | 2026-09-15 | 2026-09-17 | 9,078,529 | $22.03 | $199.99M | 11,616,986 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-10 | 2026-09-14 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | A Award deriv | 2026-09-08 | 2026-09-08 | 13,750 | — | $0 | 13,750 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise deriv | 2026-08-24 | 2026-08-26 | 1,500 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise | 2026-08-24 | 2026-08-26 | 1,500 | $3.74 | $5.6K | 1,500 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise deriv | 2026-08-24 | 2026-08-26 | 1,500 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | M Exercise | 2026-08-24 | 2026-08-26 | 1,500 | $3.74 | $5.6K | 1,500 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 725,443 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 4,777,415 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 725,443 | SEC↗ |
| SEPN Septerna, Inc. | S Sale | 2026-08-12 | 2026-08-14 | 746,500 | $42.50 | $31.73M | 4,777,415 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-31 | 2026-07-31 | 24,944 | $9.93 | $247.7K | 17,329,570 | SEC↗ |
| IKT Inhibikase Therapeutics, I | J Other deriv | 2026-07-29 | 2026-07-31 | 18,030,000 | — | $0 | 18,030,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | J Other | 2026-07-29 | 2026-07-31 | 18,030,000 | — | $0 | 6,970,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| IKT Inhibikase Therapeutics, I | J Other deriv | 2026-07-29 | 2026-07-31 | 18,030,000 | — | — | 18,030,000 | SEC↗ |
| IKT Inhibikase Therapeutics, I | J Other | 2026-07-29 | 2026-07-31 | 18,030,000 | — | — | 6,970,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-29 | 2026-07-31 | 20,824 | $9.99 | $208.0K | 17,304,626 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-24 | 2026-07-28 | 41,319 | $9.99 | $412.8K | 17,283,802 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-23 | 2026-07-23 | 59,880 | $9.96 | $596.4K | 17,242,483 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-22 | 2026-07-22 | 47,250 | $29.77 | $1.41M | 26,529,686 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-22 | 2026-07-23 | 84,124 | $9.93 | $835.4K | 17,182,603 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 37,723 | $30.00 | $1.13M | 26,482,436 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 6,504 | $29.17 | $189.7K | 26,444,713 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-21 | 2026-07-22 | 21,696 | $27.96 | $606.6K | 26,438,209 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-21 | 2026-07-23 | 120,582 | $9.55 | $1.15M | 17,098,479 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-20 | 2026-07-22 | 98,433 | $27.13 | $2.67M | 26,383,526 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-07-20 | 2026-07-22 | 32,987 | $27.72 | $914.4K | 26,416,513 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 336,965 | $10.00 | $3.37M | 1,245,068 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 4,918,411 | $10.00 | $49.18M | 12,230,122 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 367,427 | — | $0 | 367,427 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 908,103 | — | $0 | 908,103 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 553,703 | — | $0 | 553,703 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 970,950 | — | $0 | 970,950 | SEC↗ |
| FRNM Freenome, Inc. | A Award | 2026-07-20 | 2026-07-22 | 6,561,711 | — | $0 | 7,311,711 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-17 | 2026-07-20 | 7,882 | $8.95 | $70.5K | 16,977,927 | SEC↗ |
| VOR Vor Biopharma Inc. | X Exercise deriv | 2026-07-16 | 2026-07-21 | 2,100,000 | $5.00 | $10.50M | 7,900,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-16 | 2026-07-20 | 152,472 | $8.93 | $1.36M | 16,970,045 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-07-16 | 2026-07-21 | 213 | $19.75 | $4.2K | 4,501,882 | SEC↗ |
| VOR Vor Biopharma Inc. | X Exercise | 2026-07-16 | 2026-07-21 | 2,100,000 | — | $0 | 4,502,095 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-14 | 6,552 | $8.94 | $58.6K | 16,817,573 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-13 | 2026-07-23 | 6,522 | $8.94 | $58.3K | 16,817,543 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-07-10 | 2026-07-14 | 15,102 | $8.97 | $135.5K | 16,811,021 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-29 | 2026-07-01 | 70,284 | — | $0 | 70,284 | SEC↗ |
| SEPN Septerna, Inc. | A Award deriv | 2026-06-26 | 2026-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-26 | 2026-06-29 | 1,876 | $8.98 | $16.8K | 16,795,919 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-25 | 2026-06-29 | 31,000 | $8.88 | $275.3K | 16,794,043 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | A Award deriv | 2026-06-24 | 2026-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PEPG PepGen Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 34,000 | — | $0 | 34,000 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 20,275 | — | $0 | 20,275 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-17 | 2026-06-22 | 27,695 | $0.35 | $9.7K | 303,719 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-17 | 2026-06-22 | 389,216 | $0.35 | $136.2K | 4,268,448 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-16 | 2026-06-16 | 9,939 | $0.37 | $3.7K | 331,414 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-16 | 2026-06-16 | 139,686 | $0.37 | $51.7K | 4,657,664 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-16 | 2026-06-16 | 124,893 | $8.89 | $1.11M | 16,763,043 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-06-16 | 2026-06-17 | 61,523 | $24.98 | $1.54M | 6,444,637 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-15 | 22,100 | — | $0 | 22,100 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-15 | 2026-06-16 | 8,554 | $0.39 | $3.3K | 341,353 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-15 | 2026-06-16 | 120,216 | $0.39 | $46.9K | 4,797,350 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-15 | 2026-06-16 | 15,414 | $8.99 | $138.6K | 16,638,150 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-06-15 | 2026-06-17 | 6,146 | $24.89 | $153.0K | 6,383,114 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-12 | 2026-06-16 | 11,322 | $0.40 | $4.5K | 349,907 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-12 | 2026-06-16 | 159,119 | $0.40 | $63.6K | 4,917,566 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-12 | 2026-06-16 | 391,019 | $8.57 | $3.35M | 16,622,736 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 15,500 | — | $0 | 15,500 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 1,666,829 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 160,562 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 9,445,363 | — | $0 | 0 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion deriv | 2026-06-11 | 2026-06-15 | 642,250 | — | $0 | 0 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-11 | 2026-06-11 | 548,580 | $7.91 | $4.34M | 16,231,717 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-11 | 2026-06-11 | 245,066 | $0.38 | $93.1K | 5,076,685 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-11 | 2026-06-11 | 17,437 | $0.38 | $6.6K | 361,229 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,500 | — | $0 | 11,750 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-15 | 6,556,740 | — | $0 | 6,556,740 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | C Conversion | 2026-06-11 | 2026-06-15 | 1,187,881 | — | $0 | 1,187,881 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-15 | 1,460,397 | $20.00 | $29.21M | 2,648,278 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | P Buy | 2026-06-11 | 2026-06-15 | 19,728,353 | $20.00 | $394.57M | 26,285,093 | SEC↗ |
| NKTX Nkarta, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 37,000 | — | $0 | 37,000 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-10 | 2026-06-11 | 103 | $7.00 | $721 | 15,683,137 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-10 | 2026-06-11 | 3,051 | $0.37 | $1.1K | 378,666 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-10 | 2026-06-11 | 42,872 | $0.37 | $15.9K | 5,321,751 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | A Award deriv | 2026-06-09 | 2026-06-10 | 19,475 | — | $0 | 19,475 | SEC↗ |
| PBLS Parabilis Medicines, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 20,215 | — | $0 | 20,215 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-06-09 | 2026-06-11 | 479,039 | $6.91 | $3.31M | 15,683,034 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-09 | 2026-06-11 | 24,565 | $0.37 | $9.1K | 381,717 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-06-09 | 2026-06-11 | 345,235 | $0.37 | $127.7K | 5,364,623 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-06-05 | 2026-06-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award deriv | 2026-06-03 | 2026-06-05 | 53,250 | — | $0 | 53,250 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-06-03 | 2026-06-05 | 35,500 | — | $0 | 48,300 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2026-05-28 | 2026-06-01 | 13,160 | — | $0 | 13,160 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-20 | 2026-05-21 | 996 | $24.94 | $24.8K | 6,376,968 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-19 | 2026-05-21 | 3,802 | $24.97 | $94.9K | 6,375,972 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-05-18 | 2026-05-20 | 9,366 | — | $0 | 9,366 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-12 | 2026-05-12 | 94,432 | $0.64 | $60.4K | 5,709,858 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-12 | 2026-05-12 | 6,719 | $0.64 | $4.3K | 406,282 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-12 | 2026-05-14 | 6,387 | $24.90 | $159.0K | 6,372,170 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy deriv | 2026-05-11 | 2026-05-13 | 2,170,138 | $11.52 | $25.00M | 2,170,138 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-11 | 2026-05-11 | 14,149 | $24.47 | $346.2K | 6,340,063 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-11 | 2026-05-11 | 25,720 | $25.00 | $643.0K | 6,365,783 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-12 | 81,678 | $0.67 | $54.7K | 5,804,290 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-11 | 2026-05-12 | 5,812 | $0.67 | $3.9K | 413,001 | SEC↗ |
| ARTV Artiva Biotherapeutics, In | P Buy | 2026-05-11 | 2026-05-13 | 6,510,416 | $11.52 | $75.00M | 15,203,995 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-08 | 2026-05-11 | 1,483 | $24.98 | $37.0K | 6,325,914 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-08 | 2026-05-12 | 25,012 | $0.71 | $17.8K | 418,813 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2026-05-08 | 2026-05-12 | 351,514 | $0.71 | $249.6K | 5,885,968 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-07 | 2026-05-11 | 7,921 | $24.34 | $192.8K | 6,322,446 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-07 | 2026-05-11 | 1,985 | $24.95 | $49.5K | 6,324,431 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-06 | 2026-05-06 | 14,611 | $23.77 | $347.3K | 6,261,118 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-06 | 2026-05-06 | 53,407 | $24.83 | $1.33M | 6,314,525 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-05 | 2026-05-06 | 87,143 | $24.59 | $2.14M | 6,236,239 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-05 | 2026-05-06 | 10,268 | $25.00 | $256.7K | 6,246,507 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 56,972 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 64,680 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 27,720 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 10,054 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 18,146 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-06 | 42,341 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion | 2026-05-04 | 2026-05-06 | 1,009,052 | — | $0 | 1,009,052 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion | 2026-05-04 | 2026-05-06 | 221,188 | — | $0 | 221,188 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-04 | 2026-05-06 | 2,541,250 | $18.00 | $45.74M | 6,149,096 | SEC↗ |
| COAG Hemab Therapeutics Holding | P Buy | 2026-05-04 | 2026-05-06 | 133,750 | $18.00 | $2.41M | 354,938 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion | 2026-05-04 | 2026-05-06 | 3,607,846 | — | $0 | 3,607,846 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2026-04-29 | 2026-04-29 | 2,106,000 | $9.50 | $20.01M | 22,546,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | J Other deriv | 2026-04-27 | 2026-04-28 | 1,407,000 | — | $0 | 1,407,000 | SEC↗ |
| ACET Adicet Bio, Inc. | J Other deriv | 2026-04-27 | 2026-04-29 | 250,000 | — | $0 | 1,402,833 | SEC↗ |
| PRLD Prelude Therapeutics Inc | J Other | 2026-04-27 | 2026-04-28 | 1,407,000 | — | $0 | 6,475,882 | SEC↗ |
| ACET Adicet Bio, Inc. | J Other | 2026-04-27 | 2026-04-29 | 250,000 | — | $0 | 932,624 | SEC↗ |
| ACRV Acrivon Therapeutics, Inc. | A Award | 2026-04-22 | 2026-04-23 | 3,888,888 | $1.80 | $7.00M | 11,803,094 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-22 | 2026-04-24 | 165,150 | $15.77 | $2.60M | 2,402,095 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-20 | 2026-04-21 | 171,963 | $15.77 | $2.71M | 2,567,245 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-17 | 2026-04-21 | 458,411 | $16.28 | $7.46M | 2,739,208 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-15 | 2026-04-15 | 53,644 | $16.01 | $858.8K | 3,197,619 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-14 | 2026-04-15 | 153,735 | $15.97 | $2.46M | 3,251,263 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-13 | 2026-04-15 | 530,610 | $16.15 | $8.57M | 3,404,998 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-10 | 2026-04-10 | 828 | $15.75 | $13.0K | 3,935,608 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-09 | 2026-04-10 | 135,201 | $16.59 | $2.24M | 3,936,436 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-08 | 2026-04-10 | 353,242 | $16.32 | $5.76M | 4,202,499 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-08 | 2026-04-10 | 130,862 | $16.91 | $2.21M | 4,071,637 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-06 | 2026-04-06 | 537,754 | $16.51 | $8.88M | 4,607,244 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-06 | 2026-04-06 | 6,775 | $18.50 | $125.3K | 4,555,741 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-06 | 2026-04-06 | 44,728 | $17.31 | $774.2K | 4,562,516 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-02 | 2026-04-06 | 258,475 | $18.23 | $4.71M | 5,146,523 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2026-04-02 | 2026-04-06 | 1,525 | $19.06 | $29.1K | 5,144,998 | SEC↗ |
| WVE Wave Life Sciences Ltd. | P Buy | 2026-03-30 | 2026-03-30 | 971,091 | $6.50 | $6.31M | 26,975,505 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2026-03-30 | 2026-03-31 | 58,300 | $24.16 | $1.41M | 5,825,521 | SEC↗ |
| WVE Wave Life Sciences Ltd. | P Buy | 2026-03-27 | 2026-03-30 | 2,495,623 | $6.43 | $16.05M | 26,004,414 | SEC↗ |
| MLYS Mineralys Therapeutics, In | P Buy | 2026-03-27 | 2026-03-31 | 310,700 | $23.67 | $7.35M | 5,767,221 | SEC↗ |
| WVE Wave Life Sciences Ltd. | P Buy | 2026-03-26 | 2026-03-30 | 4,954,558 | $6.06 | $30.02M | 23,157,567 | SEC↗ |
| WVE Wave Life Sciences Ltd. | P Buy | 2026-03-26 | 2026-03-30 | 351,224 | $6.38 | $2.24M | 23,508,791 | SEC↗ |
| ABOS Acumen Pharmaceuticals, In | A Award | 2026-03-16 | 2026-03-18 | 6,060,606 | $3.30 | $20.00M | 19,103,785 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy deriv | 2026-02-26 | 2026-03-02 | 2,200,000 | $16.00 | $35.20M | 2,200,000 | SEC↗ |
| BCAX Bicara Therapeutics Inc. | P Buy | 2026-02-26 | 2026-03-02 | 300,000 | $16.00 | $4.80M | 4,603,418 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2026-02-20 | 2026-04-13 | 74,751 | $7.27 | $543.4K | 1,182,624 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2026-02-19 | 2026-04-13 | 74,268 | $7.21 | $535.5K | 1,107,873 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award deriv | 2026-02-19 | 2026-02-20 | 8,300 | — | $0 | 8,300 | SEC↗ |
| MLYS Mineralys Therapeutics, In | A Award | 2026-02-19 | 2026-02-20 | 6,200 | — | $0 | 6,200 | SEC↗ |
| ACET Adicet Bio, Inc. | P Buy | 2026-02-18 | 2026-04-13 | 74,577 | $7.04 | $525.0K | 1,033,605 | SEC↗ |
| EVMN Evommune, Inc. | A Award | 2026-02-17 | 2026-02-17 | 35,868 | $27.88 | $1000.0K | 2,710,293 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 222,591 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,150,941 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 767,294 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,150,941 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 272,056 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 767,294 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 2,524,473 | — | $0 | 2,524,473 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,806,644 | — | $0 | 1,806,644 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 3,441,966 | $16.00 | $55.07M | 5,966,439 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 248,034 | $16.00 | $3.97M | 2,054,678 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | A Award deriv | 2026-02-05 | 2026-02-09 | 27,400 | — | $0 | 27,400 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-09 | 22,200 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-09 | 89,956 | $15505.00 | $1.39B | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2026-01-07 | 2026-01-09 | 1,286,786 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-09 | 5,079 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-09 | 4,652,309 | $221.50 | $1.03B | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise | 2026-01-07 | 2026-01-09 | 1,286,786 | — | $0 | 4,652,309 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2026-01-05 | 2026-01-07 | 7,111 | $3.50 | $24.9K | 3,403,429 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award deriv | 2025-12-18 | 2025-12-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| VOR Vor Biopharma Inc. | A Award | 2025-12-18 | 2025-12-19 | 4,625,346 | $10.81 | $50.00M | 5,404,998 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-12 | 2025-12-15 | 101,462 | $2.86 | $290.2K | 3,396,318 | SEC↗ |
| CLYM Climb Bio, Inc. | A Award deriv | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 20,440,000 | SEC↗ |
| CLYM Climb Bio, Inc. | D To issuer | 2025-12-11 | 2025-12-15 | 20,440,000 | — | $0 | 3,081,757 | SEC↗ |
| CLYM Climb Bio, Inc. | P Buy | 2025-12-11 | 2025-12-15 | 213,099 | $2.18 | $464.6K | 3,294,856 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 2,706,397 | $14.28 | $38.65M | 6,145,682 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 91,722 | $14.98 | $1.37M | 6,053,960 | SEC↗ |
| FULC Fulcrum Therapeutics, Inc. | S Sale | 2025-12-08 | 2025-12-10 | 1,377,020 | $13.33 | $18.36M | 8,852,079 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 6,440 | $39.50 | $254.4K | 2,198,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 9,924 | $39.50 | $392.0K | 650,307 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 1,210 | $39.50 | $47.8K | 6,897,623 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-21 | 2025-11-24 | 7,609 | $39.50 | $300.6K | 159,033 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 788 | $40.50 | $31.9K | 660,231 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 604 | $40.50 | $24.5K | 166,642 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 512 | $40.50 | $20.7K | 2,204,522 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 96 | $40.50 | $3.9K | 6,898,833 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 947 | $39.89 | $37.8K | 167,246 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 801 | $39.89 | $32.0K | 2,205,034 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 1,235 | $39.89 | $49.3K | 661,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-20 | 2025-11-24 | 150 | $39.89 | $6.0K | 6,898,929 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2,276 | $40.01 | $91.1K | 6,899,081 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 18,684 | $40.01 | $747.5K | 662,266 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12,126 | $40.01 | $485.2K | 2,205,843 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 14,325 | $40.01 | $573.1K | 168,202 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 2 | $40.61 | $81 | 6,899,079 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 12 | $40.61 | $487 | 662,254 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 8 | $40.61 | $325 | 2,205,835 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-19 | 2025-11-19 | 9 | $40.61 | $365 | 168,193 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,092 | $39.57 | $82.8K | 182,527 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 332 | $39.57 | $13.1K | 6,901,357 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 2,728 | $39.57 | $107.9K | 680,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-19 | 1,770 | $39.57 | $70.0K | 2,217,969 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 2,182 | $40.20 | $87.7K | 6,903,443 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 17,913 | $40.20 | $720.1K | 698,075 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 11,626 | $40.20 | $467.4K | 2,229,082 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,734 | $40.20 | $552.1K | 195,657 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 1,701 | $41.05 | $69.8K | 6,901,742 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 13,964 | $41.05 | $573.2K | 684,111 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 9,063 | $41.05 | $372.0K | 2,220,019 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 10,707 | $41.05 | $439.5K | 184,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 331 | $42.10 | $13.9K | 184,619 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 280 | $42.10 | $11.8K | 2,219,739 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 433 | $42.10 | $18.2K | 683,678 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 53 | $42.10 | $2.2K | 6,901,689 | SEC↗ |
| WVE Wave Life Sciences Ltd. | P Buy | 2025-11-13 | 2025-11-14 | 1,000 | $6.69 | $6.7K | 18,203,009 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-11-03 | 4,331,081 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-30 | 2025-10-30 | 24,579 | $25.12 | $617.4K | 779,652 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer | 2025-10-30 | 2025-11-03 | 335,364 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer | 2025-10-30 | 2025-11-03 | 19,554,319 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-29 | 2025-10-30 | 251,518 | $25.22 | $6.34M | 804,231 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 31,392 | $39.58 | $1.24M | 715,988 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 17,118 | $39.58 | $677.5K | 2,240,708 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 10,476 | $39.58 | $414.6K | 209,391 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 3,624 | $39.58 | $143.4K | 6,905,625 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-28 | 2025-10-30 | 87,828 | $27.10 | $2.38M | 1,092,232 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-28 | 2025-10-30 | 36,483 | $28.18 | $1.03M | 1,055,749 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-27 | 2025-10-27 | 90,941 | $28.12 | $2.56M | 1,180,060 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-24 | 2025-10-27 | 53,345 | $28.01 | $1.49M | 1,271,001 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 14,116 | $39.50 | $557.6K | 6,909,249 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 107,941 | $39.50 | $4.26M | 219,867 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 122,271 | $39.50 | $4.83M | 747,380 | SEC↗ |
| SION Sionna Therapeutics, Inc. | S Sale | 2025-10-24 | 2025-10-28 | 66,672 | $39.50 | $2.63M | 2,257,826 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-23 | 2025-10-27 | 76,880 | $28.01 | $2.15M | 1,324,346 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-21 | 2025-10-22 | 25,027 | $28.11 | $703.5K | 1,401,226 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 6,553 | $30.12 | $197.4K | 1,426,253 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 1,287 | $30.12 | $38.8K | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 70,366 | $29.63 | $2.08M | 1,432,806 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-20 | 2025-10-22 | 13,817 | $29.63 | $409.4K | 1,287 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 174,594 | $29.12 | $5.08M | 1,546,621 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 2,492 | $31.00 | $77.3K | 15,104 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 12,691 | $31.00 | $393.4K | 1,503,172 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 6,040 | $30.28 | $182.9K | 17,596 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 30,758 | $30.28 | $931.4K | 1,515,863 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-17 | 2025-10-17 | 34,284 | $29.12 | $998.4K | 23,636 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 111,041 | $29.32 | $3.26M | 1,737,061 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 21,804 | $29.32 | $639.3K | 61,032 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 15,826 | $30.36 | $480.5K | 1,721,235 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 3,108 | $30.36 | $94.4K | 57,924 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 20 | $31.35 | $627 | 1,721,215 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-16 | 2025-10-17 | 4 | $31.35 | $125 | 57,920 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 234 | $31.17 | $7.3K | 1,848,102 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2025-10-15 | 2025-10-17 | 46 | $31.17 | $1.4K | 82,836 | SEC↗ |